From the telegraph 20146 Oct 2016 22:02
Jim Mellon, the biotech investor, is putting his best foot forward with his latest stock market foray.
The Diabetic Boot Company, as the medical shoe-maker is known, is currently exploring all forms of financing after an initial £1m investment round, with the preferred outcome a flotation on Aim, pencilled in for late August.
No banks have been appointed as advisers yet, but Mellon, who owns a 40pc stake in the company through his Burnbrae vehicle, estimates its IPO valuation at around £15m.
------------------------------------------------------------------